HIQA public consultation on shingles vaccine for adults
HIQA has launched a public consultation on its draft health technology assessment (HTA) of shingles (herpes zoster) vaccination for adults. Following the public consultation, the report will be updated as necessary and a finalised report will be submitted as advice to the Minister for Health, and published on the HIQA website.
The draft findings were published to give members of the public an opportunity to provide feedback on the content. The IPU intends to provide feedback on this draft HTA to HIQA and individual members may also do so. Feedback can be submitted online here.
The consultation will remain open until 5pm on Tuesday, 30 April 2024.
IPU COVID-19 Hub
The IPU COVID-19 Pharmacy Vaccination Consent Form has been updated and is available to download and review on the IPU COVID-19 Vaccination Hub.
HSE-PharmaVax User Feedback Survey
HSE-PharmaVax have launched a User Feedback Survey to obtain feedback from community pharmacists on their experience of using HSE-PharmaVax. They also wish to assess satisfaction with the support service that is currently in place.
Participation is completely voluntary and anonymous. However, if you wish to be contacted to discuss your responses further you can provide your email address.
The link to the survey is available on the landing page of HSE-PharmaVax on initial log in to the application, it is also available here. The survey will remain open until 16 May.
Comirnaty® BA.4-5 COVID-19 Primary Course Payments
HSE PCRS has informed the IPU of a payment issue that occurred when Comirnaty® BA.4-5 was recorded on HSE PharmaVax as a COVID-19 Primary Course Vaccination between 21 April 2023 and 14 September 2023. In April 2023 Comirnaty® BA.4-5 was approved for Primary Course Vaccinations, until then it had only been approved for booster doses. While HSE PharmaVax allowed for these primary course vaccinations to be recorded accurately, the system did not trigger a primary course payment. The issue has been resolved and members will receive payment for these vaccinations in the next payment cycle.
